CGNX Документы SEC - Cognex Corporation- Годовой отчет, доверенное заявление, проспект эмиссии

Основная статистика

LEI	549300JQTYZCLC43S226
CIK	851205

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Cognex Corporation

SEC Filings (Chronological Order)

На этой странице представлен полный хронологический список документов SEC, за исключением документов о собственности, которые мы предоставляем в других местах.

July 31, 2025	EX-10.1	Transition Agreement, effective as of April 30, 2025, by and between Cognex Corporation and Robert Willett* willetttransitionagreeme Exhibit 10.1 TRANSITION AGREEMENT This TRANSITION AGREEMENT is entered into as of April 30, 2025 (the “Effective Date”), by and between Cognex Corporation, a Massachusetts corporation with a principal place of business at One Vision Drive, Natick, Massachusetts 01760 (with its affiliates, subsidiaries, successors and assigns as presently constituted and as may be establish
July 31, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended June 29, 2025 or ☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 001-34218 COGNEX CORP
July 30, 2025	EX-99.1	COGNEX CORPORATION CONSOLIDATED BALANCE SHEETS (in thousands) June 29, 2025 December 31, 2024 (unaudited) ASSETS Current assets: Cash and cash equivalents $ 179,311 $ 186,094 Current investments, allowance for credit losses of $0 in 2025 and 2024 48, Exhibit 99.1 Cognex Reports Second Quarter 2025 Results July 30, 2025 — NATICK, MA — Cognex Corporation (NASDAQ: CGNX), the global technology leader in industrial machine vision, today reported financial results for the second quarter ended June 29, 2025. Second-Quarter Financial and Operating Highlights •Revenue grew 4% year over year or 3% on a constant-currency basis. •Operating expenses declin
July 30, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 30, 2025 Date of Report (date of earliest event reported) Cognex Corporation ( UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 30, 2025 Date of Report (date of earliest event reported) Cognex Corporation (Exact name of registrant as specified in its charter) Massachusetts (State or other jurisdiction of incorporation or organization) 001-34218 (Commissi
May 23, 2025	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report COGNEX CORPORATION (Exact name of registrant as specified in its charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report COGNEX CORPORATION (Exact name of registrant as specified in its charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) One Vision Drive, Natick, Massachusetts 01760-2059 (Address
May 23, 2025	EX-1.01	Exhibit 1.01 - Conflict Minerals Report for the calendar year ended December 31, 2024 EXHIBIT 1.01 COGNEX CORPORATION CONFLICT MINERALS REPORT FOR THE YEAR ENDED DECEMBER 31, 2024 Cognex Corporation (the "Company") is a leading global provider of machine vision products and solutions that improve efficiency and quality in a wide range of businesses across attractive industrial end markets. The Company specializes in machine vision products that are used to automate the manufacturin
May 1, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 30, 2025 or ☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 001-34218 COGNEX COR
May 1, 2025	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 30, 2025 Date of Report (date of earliest event reported) Cognex Corporation (Exact name of registrant as specified in its charter) Massachusetts (State or other jurisdiction of incorporation or organization) 001-34218 (Commiss
April 30, 2025	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 30, 2025 Date of Report (date of earliest event reported) Cognex Corporation (Exact name of registrant as specified in its charter) Massachusetts (State or other jurisdiction of incorporation or organization) 001-34218 (Commiss
April 30, 2025	EX-99.1	Three Months Ended March 30, 2025 Three Months Ended March 31, 2024 Y/Y Change Revenue $216 $211 +2% Operating Income $26 $14 +84% % of Revenue 12.1% 6.7% +540 bps Adjusted EBITDA* $36 $25 +44% % of Revenue 16.8% 11.9% +490 bps Net Income per Diluted Exhibit 99.1 Cognex Reports First Quarter 2025 Results; Announces CEO Transition April 30, 2025―NATICK, MA—Cognex Corporation (NASDAQ: CGNX) today reported financial results for the first quarter ended March 30, 2025. First-Quarter Financial and Operating Highlights •Revenue grew 2% year-on-year or 5% on a constant-currency basis •Operating expenses declined 7% year-on-year, driven primarily by co
March 14, 2025	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for
March 14, 2025	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidenti
February 20, 2025	EX-3.1	Second Amended and Restated By-laws of Cognex Corporation, effective February 19, 2025 Exhibit 3.1 SECOND AMENDED AND RESTATED BY-LAWS OF COGNEX CORPORATION TABLE OF CONTENTS Page ARTICLE 1 Articles of Organization 1 ARTICLE 2 Fiscal Year 1 ARTICLE 3 Meetings of Shareholders 2 Section 3.1 Annual Meeting 2 Section 3.2 Special Meetings 10 Section 3.3 Place of Meetings 11 Section 3.4 Notice of Meetings 11 Section 3.5 Quorum; Voting 12 Section 3.6 Action without Meeting 14 Section 3.
February 20, 2025	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 19, 2025 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
February 13, 2025	EX-19	Cognex Corporation Insider Trading Policy (filed herewith) a2024insidertradingpolic Insider Trading Policy Version: 3.0 Cognex Corporation Insider Trading Policy 1.0 POLICY OBJECTIVE, PURPOSE, SCOPE, REFERENCES 1.1 Objective The objective of this Policy is to help non-employee members of Cognex Corporation’s board of directors (“Directors”), officers of Cognex Corporation or an affiliate of Cognex Corporation (“Officers”), and employees of Cognex Corporat
February 13, 2025	EX-21	Subsidiaries of the registrant (filed herewith) EXHIBIT 21 COGNEX CORPORATION SUBSIDIARIES OF THE REGISTRANT As of December 31, 2024, the registrant had the following direct and indirect subsidiaries, the financial statements of which are all included in the consolidated financial statements of the registrant: NAME OF SUBSIDIARY STATE/COUNTRY OF INCORPORATION PERCENT OWNERSHIP Cognex Canada, Inc.
February 13, 2025	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Content UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2024 or ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File Number 001-34
February 12, 2025	EX-99.1	Table 1 (Dollars in millions, except per share amounts) Exhibit 99.1 Cognex Reports Fourth Quarter 2024 Results February 12, 2025―NATICK, MA—Cognex Corporation (NASDAQ: CGNX) today reported financial results for the fourth quarter and full year 2024. Table 1 below shows selected financial data for Q4-24 and the full year 2024 compared with Q4-23 and the full year 2023. “Cognex delivered strong results in the fourth quarter, with revenue at the high end
February 12, 2025	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 12, 2025 Date of Report (date of earliest event reported) Cognex Corporation (Exact name of registrant as specified in its charter) Massachusetts (State or other jurisdiction of incorporation or organization) 001-34218 (Comm
October 31, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 29, 2024 or ☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 001-34218 COGNEX
October 30, 2024	EX-99.1	Table 1 (Dollars in millions, except per share amounts) Exhibit 99.1 Cognex Reports Third Quarter 2024 Results October 30, 2024―NATICK, MA—Cognex Corporation (NASDAQ: CGNX) today reported financial results for the third quarter of 2024. Table 1 below shows selected financial data for Q3-24 compared with Q3-23 and Q2-24. “Cognex generated third quarter revenue and adjusted EBITDA margin in line with our guidance," said Robert J. Willett, CEO. "Revenue g
October 30, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 30, 2024 Date of Report (date of earliest event reported) Cognex Corporation (Exact name of registrant as specified in its charter) Massachusetts (State or other jurisdiction of incorporation or organization) 001-34218 (Commi
August 1, 2024	EX-10.1	Relocation Letter Agreement, effective as of April 22, 2024, by and between Cognex Corporation and Dennis Fehr* Cognex Corporation One Vision Drive Natick, MA 01760-2059 (508) 650-3000 fax (508) 650-3333 www.
August 1, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended June 30, 2024 or ☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 001-34218 COGNEX CORP
July 31, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 31, 2024 Date of Report (date of earliest event reported) Cognex Corporation (Exact name of registrant as specified in its charter) Massachusetts (State or other jurisdiction of incorporation or organization) 001-34218 (Commissi
July 31, 2024	EX-99.1	Table 1 (Dollars in millions, except per share amounts) Exhibit 99.1 Cognex Reports Second Quarter 2024 Results July 31, 2024―NATICK, MA—Cognex Corporation (NASDAQ: CGNX) today reported financial results for the second quarter of 2024. Table 1 below shows selected financial data for Q2-24 compared with Q2-23 and Q1-24. “Cognex delivered second quarter revenue and gross margin in line with expectations and operating expenses favorable to our guidance,"
May 24, 2024	EX-1.01	Exhibit 1.01 - Conflict Minerals Report for the calendar year ended December 31, 202 EXHIBIT 1.01 COGNEX CORPORATION CONFLICT MINERALS REPORT FOR THE YEAR ENDED DECEMBER 31, 2023 Cognex Corporation (the "Company") is a leading global provider of machine vision products and solutions that improve efficiency and quality in a wide range of businesses across attractive industrial end markets. The Company specializes in machine vision products that are used to automate the manufacturin
May 24, 2024	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report COGNEX CORPORATION (Exact name of registrant as specified in its charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report COGNEX CORPORATION (Exact name of registrant as specified in its charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) One Vision Drive, Natick, Massachusetts 01760-2059 (Address
May 2, 2024	EX-99.1	Table 1 (Dollars in thousands, except per share amounts) Exhibit 99.1 Cognex Reports First Quarter 2024 Results May 2, 2024―NATICK, MA—Cognex Corporation (NASDAQ: CGNX) today reported financial results for the first quarter of 2024. Table 1 below shows selected financial data for Q1-24 compared with Q1-23 and Q4-23. “Our first quarter results reflected a challenging, yet stable business environment,” said Robert J. Willett, CEO of Cognex. “Revenue acros
May 2, 2024	EX-10.1	Letter Agreement dated January 3, 2024 between Cognex Corporation and Paul D. Todgham* exhibit101-ptagreement Exhibit 10.1 Cognex Corporation One Vision Drive Natick, MA 01760-2059 (508) 650-3000 www.cognex.com PERSONAL AND CONFIDENTIAL Paul Todgham [Address] Re: Resignation Agreement Dear Paul: This letter confirms your upcoming separation from employment with Cognex Corporation (the “Company”). This letter also proposes an agreement between you and the Company. Entitlements and Ob
May 2, 2024	EX-99.2	Cognex Names Dennis Fehr as Chief Financial Officer Exhibit 99.2 Cognex Names Dennis Fehr as Chief Financial Officer NATICK, MA, May 2, 2024 - Cognex Corporation (NASDAQ: CGNX), a leading provider of machine vision for factory and warehouse automation, today announced the appointment of Dennis Fehr as Senior Vice President of Finance and Chief Financial Officer, effective May 3, 2024. In this role, Fehr will lead Cognex’s global finance and informa
May 2, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2024 or ☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 001-34218 COGNEX COR
May 2, 2024	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 1, 2024 Date of Report (date of earliest event reported) Cognex Corporation (Exact name of registrant as specified in its charter) Massachusetts (State or other jurisdiction of incorporation or organization) 001-34218 (Commission
May 2, 2024	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 1, 2024 Date of Report (date of earliest event reported) Cognex Corporation (Exact name of registrant as specified in its charter) Massachusetts (State or other jurisdiction of incorporation or organization) 001-34218 (Commission
March 15, 2024	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential , fo
March 15, 2024	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 13, 2024 Date of Report (date of earliest event reported) Cognex Corporation (Exact name of registrant as specified in its charter) Massachusetts (State or other jurisdiction of incorporation or organization) 001-34218 (Commiss
March 15, 2024	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for
March 8, 2024	SC 13G	CGNX / Cognex Corporation / GIC Private Ltd - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) * COGNEX CORPORATION (Name of Issuer) Common Stock, $0.002 par value per share (Title of Class of Securities) 192422103 (CUSIP Number) March 5, 2024 (Date of the Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule
February 15, 2024	EX-21	Subsidiaries of the registrant (filed herewith) EXHIBIT 21 COGNEX CORPORATION SUBSIDIARIES OF THE REGISTRANT As of December 31, 2023, the registrant had the following direct and indirect subsidiaries, the financial statements of which are all included in the consolidated financial statements of the registrant: NAME OF SUBSIDIARY STATE/COUNTRY OF INCORPORATION PERCENT OWNERSHIP Cognex Canada, Inc.
February 15, 2024	EX-99.1	Cognex Reports Fourth Quarter and Full Year 2023 Results February 15, 2024―NATICK, MA—Cognex Corporation (NASDAQ: CGNX) today reported financial results for the fourth quarter and full year 2023. Table 1 below shows selected financial data for Q4-23 Cognex Reports Fourth Quarter and Full Year 2023 Results February 15, 2024―NATICK, MA—Cognex Corporation (NASDAQ: CGNX) today reported financial results for the fourth quarter and full year 2023.
February 15, 2024	EX-97	Policy Relating to Recovery of Erroneously Awarded Compensation (as required by applicable listing standards adopted pursuant to 17 CFR 240.10D-1) COGNEX CORPORATION COMPENSATION RECOVERY POLICY Adopted as of August 2, 2023 Cognex Corporation, a Massachusetts corporation (the “Company”), has adopted a Compensation Recovery Policy (this “Policy”) as described below.
February 15, 2024	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Content UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2023 or ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File Number 001-34
February 15, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 15, 2024 Date of Report (date of earliest event reported) Cognex Corporation (Exact name of registrant as specified in its charter) Massachusetts (State or other jurisdiction of incorporation or organization) 001-34218 (Comm
February 13, 2024	SC 13G/A	CGNX / Cognex Corporation / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 13)* Name of issuer: Cognex Corp Title of Class of Securities: Common Stock CUSIP Number: 192422103 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 1
January 3, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 3, 2024 Cognex Corporation UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 3, 2024 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
October 31, 2023	EX-99.1	Cognex Reports Third Quarter 2023 Results Exhibit 99.1 Cognex Reports Third Quarter 2023 Results NATICK, Mass.-(BUSINESS WIRE)-October 31, 2023-Cognex Corporation (NASDAQ: CGNX) today reported financial results for the third quarter of 2023. Table 1 below shows selected financial data for Q3-23 compared with Q3-22, and for the first nine months of 2023 compared with the same period in 2022. “We delivered third quarter revenue, gross margi
October 31, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 31, 2023 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
October 31, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended October 1, 2023 or ☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 001-34218 COGNEX CO
October 18, 2023	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 18, 2023 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
September 11, 2023	SC 13G/A	CGNX / Cognex Corp. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 12)* Name of issuer: Cognex Corp. Title of Class of Securities: Common Stock CUSIP Number: 192422103 Date of Event Which Requires Filing of this Statement: August 31, 2023 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13
August 29, 2023	EX-99.1	Cognex To Acquire Moritex Corporation, A Global Leader In Machine Vision Optics Components And Advanced Imaging Solutions EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Cognex To Acquire Moritex Corporation, A Global Leader In Machine Vision Optics Components And Advanced Imaging Solutions • Expansion of product portfolio to include optics components enables a more comprehensive customer offering. • Deepens Cognex’s penetration of important, high-growth machine vision market in Japan. • Acquisition price of ¥40 billion (
August 29, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 29, 2023 Cognex Corporation UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 29, 2023 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
August 3, 2023	EX-3.1	Amended and Restated By-laws of Cognex Corporation, effective August 2, 2023 Exhibit 3.1 AMENDED AND RESTATED BY-LAWS OF COGNEX CORPORATION TABLE OF CONTENTS Page ARTICLE 1 Articles of Organization 1 ARTICLE 2 Fiscal Year 1 ARTICLE 3 Meetings of Shareholders 1 Section 3.1 Annual Meeting 1 Section 3.2 Special Meetings 9 Section 3.3 Place of Meetings 10 Section 3.4 Notice of Meetings 11 Section 3.5 Quorum; Voting 12 Section 3.6 Action without Meeting 14 Section 3.7 Proxies a
August 3, 2023	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 2, 2023 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
August 3, 2023	EX-99.1	Cognex Reports Second Quarter 2023 Results Exhibit 99.1 Cognex Reports Second Quarter 2023 Results NATICK, Mass.-(BUSINESS WIRE)-August 3, 2023-Cognex Corporation (NASDAQ: CGNX) today reported financial results for the second quarter of 2023. Table 1 below shows selected financial data for Q2-23 compared with Q2-22, and for the first six months of 2023 compared with the same period in 2022. “We delivered second quarter revenue at the top e
August 3, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended July 2, 2023 or ☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 001-34218 COGNEX CORPO
May 19, 2023	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report COGNEX CORPORATION (Exact name of registrant as specified in its charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report COGNEX CORPORATION (Exact name of registrant as specified in its charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) One Vision Drive, Natick, Massachusetts 01760-2059 (Address
May 19, 2023	EX-1.01	COGNEX CORPORATION EXHIBIT 1.01 COGNEX CORPORATION CONFLICT MINERALS REPORT FOR THE YEAR ENDED DECEMBER 31, 2022 Cognex Corporation (the "Company") is a leading global provider of machine vision products and solutions that improve efficiency and quality in a wide range of businesses across attractive industrial end markets. The Company specializes in machine vision products that are used to automate the manufacturin
May 5, 2023	S-8 POS	As filed with the Securities and Exchange Commission on May 5, 2023 As filed with the Securities and Exchange Commission on May 5, 2023 Registration No.
May 5, 2023	S-8 POS	As filed with the Securities and Exchange Commission on May 5, 2023 S-8 POS As filed with the Securities and Exchange Commission on May 5, 2023 Registration No.
May 5, 2023	S-8 POS	As filed with the Securities and Exchange Commission on May 5, 2023 As filed with the Securities and Exchange Commission on May 5, 2023 Registration No.
May 5, 2023	S-8	As filed with the Securities and Exchange Commission on May 5, 2023 As filed with the Securities and Exchange Commission on May 5, 2023 Registration No.
May 5, 2023	S-8 POS	As filed with the Securities and Exchange Commission on May 5, 2023 S-8 POS As filed with the Securities and Exchange Commission on May 5, 2023 Registration No.
May 5, 2023	EX-FILING FEES	Filing Fee Table. EX-FILING FEES Exhibit 107.1 Calculation of Filing Fee Tables Form S-8 (Form Type) Cognex Corporation (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price per Share Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stoc
May 4, 2023	EX-10.3	Form of Restricted Stock Unit Award Agreement under the Cognex Corporation 2023 Stock Option and Incentive Plan. EX-10.3 Exhibit 10.3 RESTRICTED STOCK UNIT AWARD AGREEMENT UNDER THE COGNEX CORPORATION 2023 STOCK OPTION AND INCENTIVE PLAN Name of Grantee: No. of Restricted Stock Units: Grant Date: Pursuant to the Cognex Corporation 2023 Stock Option and Incentive Plan, as amended through the date hereof (the “Plan”), Cognex Corporation (the “Company”) hereby grants an award of the number of Restricted Stock U
May 4, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended April 2, 2023 or ☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 001-34218 COGNEX CORP
May 4, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 4, 2023 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
May 4, 2023	EX-10.1	Cognex Corporation 2023 Stock Option and Incentive Plan (incorporated herein by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, as filed with the SEC on May 4, 2023). EX-10.1 Exhibit 10.1 COGNEX CORPORATION 2023 STOCK OPTION AND INCENTIVE PLAN SECTION 1. GENERAL PURPOSE OF THE PLAN; DEFINITIONS The name of the plan is the Cognex Corporation 2023 Stock Option and Incentive Plan (the “Plan”). The purpose of the Plan is to encourage and enable the officers, employees, Non-Employee Directors and Consultants of Cognex Corporation (the “Company”) and its Affiliates u
May 4, 2023	EX-99.1	Cognex Reports First Quarter 2023 Results Exhibit 99.1 Cognex Reports First Quarter 2023 Results NATICK, Mass.-(BUSINESS WIRE)-May 4, 2023-Cognex Corporation (NASDAQ: CGNX) today reported financial results for the first quarter of 2023. Table 1 below shows selected financial data for Q1-23 compared with Q1-22. “As expected, in the first quarter our largest e-commerce customers continued to absorb excess capacity and our factory automation
May 4, 2023	EX-10.4	Form of Performance Restricted Stock Unit Award Agreement under the Cognex Corporation 2023 Stock Option and Incentive Plan. EX-10.4 EXHIBIT 10.4 PERFORMANCE RESTRICTED STOCK UNIT AWARD AGREEMENT UNDER THE COGNEX CORPORATION 2023 STOCK OPTION AND INCENTIVE PLAN Pursuant to the Cognex Corporation 2023 Stock Option and Incentive Plan as amended through the date hereof (the “Plan”) and this Performance Restricted Stock Unit Award Agreement (the “Agreement”), Cognex Corporation (the “Company”) hereby grants an award of the
May 4, 2023	EX-10.2	Form of Non-Qualified Stock Option Agreement under the Cognex Corporation 2023 Stock Option and Incentive Plan. EX-10.2 EXHIBIT 10.2 NON-QUALIFIED STOCK OPTION AGREEMENT UNDER THE COGNEX CORPORATION 2023 STOCK OPTION AND INCENTIVE PLAN Name of Optionee: No. of Option Shares: Option Exercise Price per Share: $ [FMV on Grant Date] Grant Date: Expiration Date: Pursuant to the Cognex Corporation 2023 Stock Option and Incentive Plan as amended through the date hereof (the “Plan”), Cognex Corporation (the “Compan
May 4, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 3, 2023 Cognex Corporation (Exa UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 3, 2023 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
March 21, 2023	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, fo
March 17, 2023	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confid
March 17, 2023	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 DEFA14A 1 d422486ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Prox
February 16, 2023	EX-21	Subsidiaries of the registrant (filed herewith) EXHIBIT 21 COGNEX CORPORATION SUBSIDIARIES OF THE REGISTRANT As of December 31, 2022, the registrant had the following direct and indirect subsidiaries, the financial statements of which are all included in the consolidated financial statements of the registrant: NAME OF SUBSIDIARY STATE/COUNTRY OF INCORPORATION PERCENT OWNERSHIP Cognex Asia, Inc.
February 16, 2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 15, 2023 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
February 16, 2023	EX-99.1	Cognex Reports Fourth Quarter and Full Year 2022 Results Exhibit 99.1 Cognex Reports Fourth Quarter and Full Year 2022 Results NATICK, Mass.-(BUSINESS WIRE)-February 16, 2023-Cognex Corporation (NASDAQ: CGNX) today reported financial results for 2022. Table 1 below shows selected financial data for Q4-22 compared with Q4-21 and Q3-22, and the year ended December 31, 2022 compared with the year ended December 31, 2021. “Our fourth quarter results were in
February 16, 2023	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Content UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2022 or ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File Number 001-34
February 16, 2023	EX-99.2	Cognex Announces Appointment of New Board Member and Retirement of Two Board Members Exhibit 99.2 Cognex Announces Appointment of New Board Member and Retirement of Two Board Members NATICK, Mass.-(BUSINESS WIRE)-February 16, 2023-Cognex Corporation (NASDAQ: CGNX) today announced the appointment of Angelos Papadimitriou to Cognex’s Board of Directors, effective on February 17, 2023. Papadimitriou will serve on the Audit Committee. “We are excited for Angelos to join our board,” sa
February 9, 2023	SC 13G/A	CGNX / Cognex Corporation / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0613-cognexcorp.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 11)* Name of issuer: Cognex Corp. Title of Class of Securities: Common Stock CUSIP Number: 192422103 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule p
November 3, 2022	EX-99.1	Cognex Reports Third Quarter 2022 Results Exhibit 99.1 Cognex Reports Third Quarter 2022 Results NATICK, Mass.-(BUSINESS WIRE)-November 3, 2022-Cognex Corporation (NASDAQ: CGNX) today reported financial results for the third quarter of 2022. Table 1 below shows selected financial data for Q3-22 compared with Q3-21 and Q2-22, and for the nine months of 2022 compared with the same period in 2021. Table 1 (Dollars in thousands, except per sh
November 3, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended October 2, 2022 or ☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 001-34218 COGNEX CO
November 3, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 3, 2022 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
September 19, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 19, 2022 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
September 19, 2022	EX-99.1	Cognex Increases Revenue Guidance for the Third Quarter Prior to Analyst Day Exhibit 99.1 Cognex Increases Revenue Guidance for the Third Quarter Prior to Analyst Day NATICK, Mass.-(BUSINESS WIRE)-September 19, 2022-Cognex Corporation (NASDAQ: CGNX) today announced that it has increased its revenue guidance for the third quarter of 2022 ahead of the company?s triennial Analyst Day. The company now expects revenue to be between $195 million and $205 million as compared to t
August 2, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended July 3, 2022 or ☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 001-34218 COGNEX CORPO
August 2, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 2, 2022 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
August 2, 2022	EX-99.1	Cognex Reports Second Quarter 2022 Results Exhibit 99.1 Cognex Reports Second Quarter 2022 Results NATICK, Mass.-(BUSINESS WIRE)-August 2, 2022-Cognex Corporation (NASDAQ: CGNX) today reported financial results for the second quarter of 2022. Table 1 below shows selected financial data for Q2-22 compared with Q2-21 and Q1-22, and for the six months of 2022 compared with the same period in 2021. Notably, Cognex recorded a charge of $17.4 mi
June 8, 2022	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 7, 2022 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
May 20, 2022	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report COGNEX CORPORATION (Exact name of registrant as specified in its charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of SD 1 formsd2021.htm SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report COGNEX CORPORATION (Exact name of registrant as specified in its charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) One Vision Drive, Natick, Massachuse
May 20, 2022	EX-1.01	COGNEX CORPORATION EXHIBIT 1.01 COGNEX CORPORATION CONFLICT MINERALS REPORT FOR THE YEAR ENDED DECEMBER 31, 2021 Cognex Corporation (the "Company") is a leading worldwide provider of machine vision products that capture and analyze visual information in order to automate manufacturing and distribution tasks where vision is required. The Company specializes in machine vision systems that are used to automate the manu
May 5, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 4, 2022 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
May 5, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended April 3, 2022 or ? Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 001-34218 COGNEX CORP
May 5, 2022	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 4, 2022 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
May 5, 2022	EX-99.1	Cognex Reports First Quarter 2022 Results Exhibit 99.1 Cognex Reports First Quarter 2022 Results NATICK, Mass.-(BUSINESS WIRE)-May 5, 2022-Cognex Corporation (NASDAQ: CGNX) today reported financial results for the first quarter of 2022. Table 1 below shows selected financial data for Q1-22 compared with Q1-21 and Q4-21. Table 1 (Dollars in thousands, except per share amounts) Revenue Net Income Net Income per Diluted Share Non-GAAP Net In
May 5, 2022	EX-99.2	Cognex Appoints New Board Member Exhibit 99.2 Cognex Appoints New Board Member NATICK, Mass.-(BUSINESS WIRE)-May 5, 2022-Cognex Corporation (NASDAQ: CGNX) today announced the appointment of Dr. John T.C. Lee, President and Chief Executive Officer of MKS Instruments, Inc., to Cognex?s Board of Directors, effective immediately. Dr. Lee will serve on the Audit Committee and Compensation/Stock Option Committee. ?We are pleased to wel
March 18, 2022	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of
March 18, 2022	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confid
March 3, 2022	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 3, 2022 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
March 3, 2022	EX-99.1	Cognex Authorizes New Stock Buyback Program Exhibit 99.1 Cognex Authorizes New Stock Buyback Program NATICK, Mass.-(BUSINESS WIRE)-March 3, 2022-Cognex Corporation (NASDAQ: CGNX) today announced that the company?s Board of Directors has authorized the purchase of up to $500 million of Cognex common stock in open market transactions or otherwise, subject to market conditions and other relevant factors. Cognex recently completed its previous
February 17, 2022	EX-99.1	Cognex Reports Record Results for Fiscal Year 2021 Exhibit 99.1 Cognex Reports Record Results for Fiscal Year 2021 Machine Vision Company Surpasses $1 Billion of Annual Revenue for the First Time NATICK, Mass.-(BUSINESS WIRE)-February 17, 2022-Cognex Corporation (NASDAQ: CGNX) today announced that for the year ended December 31, 2021, the company set records for annual revenue, net income, and net income per share from continuing operations. The c
February 17, 2022	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Content UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2021 or ? Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File Number 001-34
February 17, 2022	EX-21	Subsidiaries of the registrant (filed herewith) EXHIBIT 21 COGNEX CORPORATION SUBSIDIARIES OF THE REGISTRANT As of December 31, 2021, the registrant had the following direct and indirect subsidiaries, the financial statements of which are all included in the consolidated financial statements of the registrant: NAME OF SUBSIDIARY STATE/COUNTRY OF INCORPORATION PERCENT OWNERSHIP Cognex Asia, Inc.
February 17, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 17, 2022 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
February 17, 2022	EX-10.L	Form of Performance Restricted Stock Unit Agreement under the 2007 Stock Option and Incentive Plan ((incorporated by reference to Exhibit 10L of Cognex’s Annual Report on Form 10-K for the year ended December 31, 2021 [File No. 1-34218])) Exhibit 10L 1 PERFORMANCE RESTRICTED STOCK UNIT AWARD AGREEMENT Pursuant to the Cognex Corporation 2007 Stock Option and Incentive Plan as amended through the date hereof (the ?Plan?) and this Performance Restricted Stock Unit Award Agreement (the ?Agreement?), Cognex Corporation (the ?Company?) hereby grants an award of the target number of Restricted Stock Units listed below assuming target performance (?Award?) to the individual named below (?Grantee?), and Grantee hereby accepts such Award subject to all of the terms and conditions herein.
February 14, 2022	SC 13G/A	CGNX / Cognex Corporation / BROWN CAPITAL MANAGEMENT LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 4)* Cognex Corporation (Name of Issuer) Common Stock, $.002 par value (Title of Class of Securities) 192422103 (CUSIP Number) Eddie C. Brown Brown Capital Man
February 9, 2022	SC 13G/A	CGNX / Cognex Corporation / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 10)* Name of issuer: Cognex Corp. Title of Class of Securities: Common Stock CUSIP Number: 192422103 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ??Rule
November 9, 2021	EX-99.2	Cognex Appoints New Board Member Exhibit 99.2 Cognex Appoints New Board Member NATICK, Mass.-(BUSINESS WIRE)-November 4, 2021-Cognex Corporation (NASDAQ: CGNX) today announced the appointment of Marjorie T. Sennett to Cognex?s Board of Directors, effective immediately. Ms. Sennett will serve on the Audit Committee. ?We are excited for Marjorie to join our board,? said Anthony Sun, Chairman of Cognex. ?Her public board experience,
November 9, 2021	8-K/A	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 3, 2021 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
November 4, 2021	EX-99.1	Cognex Reports Record Quarterly Revenue Exhibit 99.1 Cognex Reports Record Quarterly Revenue NATICK, Mass.-(BUSINESS WIRE)-November 4, 2021-Cognex Corporation (NASDAQ: CGNX) today reported financial results for the third quarter of 2021 which included record quarterly revenue. Table 1 below shows selected financial data for Q3-21 compared with Q3-20 and Q2-21, and for the nine months of 2021 compared with the same period in 2020. Table
November 4, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended October 3, 2021 or ? Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 001-34218 COGNEX CO
November 4, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 3, 2021 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
August 5, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 5, 2021 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
August 5, 2021	EX-99.1	Cognex Reports Record Quarterly Revenue Exhibit 99.1 Cognex Reports Record Quarterly Revenue NATICK, Mass.-(BUSINESS WIRE)-August 5, 2021-Cognex Corporation (NASDAQ: CGNX) today reported financial results for the second quarter of 2021. Cognex announced the highest quarterly revenue in the company?s 40-year history and new records for second quarter revenue, net income, and net income per diluted share. Table 1 below shows selected fina
August 5, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended July 4, 2021 or ? Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 001-34218 COGNEX CORPO
May 21, 2021	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report COGNEX CORPORATION (Exact name of registrant as specified in its charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report COGNEX CORPORATION (Exact name of registrant as specified in its charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) One Vision Drive, Natick, Massachusetts 01760-2059 (Address
May 21, 2021	EX-1.01	COGNEX CORPORATION EXHIBIT 1.01 COGNEX CORPORATION CONFLICT MINERALS REPORT FOR THE YEAR ENDED DECEMBER 31, 2020 Cognex Corporation (the "Company") is a leading worldwide provider of machine vision products that capture and analyze visual information in order to automate manufacturing and distribution tasks where vision is required. The Company specializes in machine vision systems that are used to automate the manu
May 6, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 6, 2021 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
May 6, 2021	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 5, 2021 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
May 6, 2021	EX-99.1	Cognex Reports Record First Quarter Results Exhibit 99.1 Cognex Reports Record First Quarter Results NATICK, Mass.-(BUSINESS WIRE)-May 6, 2021-Cognex Corporation (NASDAQ:CGNX) today reported financial results for the first quarter of 2021. The company announced new records for first quarter revenue, net income, and net income per diluted share. Table 1 below shows selected financial data for Q1-21 compared with Q1-20 and Q4-20. Table 1 (Dol
May 6, 2021	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended April 4, 2021 or ? Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 001-34218 COGNEX CORP
March 23, 2021	DEFA14A	- DEFA14A SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
March 23, 2021	DEF 14A	- DEF 14A Table of Contents SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
February 12, 2021	SC 13G/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 3)* Cogn UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 3)* Cognex Corporation (Name of Issuer) Common Stock, $.002 par value (Title of Class of Securities) 192422103 (CUSIP Number) Eddie C. Brown Brown Capital Man
February 11, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 11, 2021 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
February 11, 2021	10-K	Annual Report - 10-K Table of Content UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2020 or ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File Number 001-34
February 11, 2021	EX-21	Subsidiaries of the registrant (filed herewith) EXHIBIT 21 COGNEX CORPORATION SUBSIDIARIES OF THE REGISTRANT As of December 31, 2020, the registrant had the following direct and indirect subsidiaries, the financial statements of which are all included in the consolidated financial statements of the registrant: NAME OF SUBSIDIARY STATE/COUNTRY OF INCORPORATION PERCENT OWNERSHIP Cognex Asia, Inc.
February 11, 2021	EX-99.1	Cognex Announces Q4 2020 Results Exhibit 99.1 Cognex Announces Q4 2020 Results Cognex Reports Record Fourth Quarter and Full Year Revenue for 2020 NATICK, Mass.-(BUSINESS WIRE)-February 11, 2021-Cognex Corporation (NASDAQ: CGNX) today reported financial results for 2020. Table 1 below shows selected financial data for Q4-20 compared with Q4-19 and Q3-20, and the year ended December 31, 2020 compared with the year ended December 3
February 10, 2021	SC 13G/A	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 9)* SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 9)* Name of issuer: Cognex Corp. Title of Class of Securities: Common Stock CUSIP Number: 192422103 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 1
December 7, 2020	8-K	- COGNEX CORPORATION 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 3, 2020 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
December 7, 2020	EX-99.1	Cognex Appoints New Board Member Exhibit 99.1 Cognex Appoints New Board Member NATICK, Mass.-(BUSINESS WIRE)-December 7, 2020-Cognex Corporation (NASDAQ: CGNX) today announced the appointment of Sachin S. Lawande, President and Chief Executive Officer of Visteon Corporation, to Cognex’s board of directors effective January 1, 2021. He is expected to serve on the Audit Committee. “We are very excited about Sachin joining our board
December 3, 2020	EX-99.1	Cognex Declares Very Special Cash Dividend of $2 Per Share EX-99.1 2 a52342757ex991.htm EXHIBIT 99.1 Exhibit 99.1 Cognex Declares Very Special Cash Dividend of $2 Per Share NATICK, Mass.-(BUSINESS WIRE)-December 3, 2020-Cognex Corporation (NASDAQ: CGNX) announced today that the company’s Board of Directors declared a “very special” cash dividend of $2.00 per share, payable on December 28, 2020 to all shareholders of record at the close of business on Dece
December 3, 2020	8-K	Financial Statements and Exhibits, Other Events - COGNEX CORPORATION 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 3, 2020 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
October 28, 2020	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 27, 2020 or ☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 001-34218 COGNEX
October 28, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events - COGNEX CORPORATION 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 28, 2020 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
October 28, 2020	EX-99.1	Cognex Reports Strong Results for the Third Quarter of 2020 Exhibit 99.1 Cognex Reports Strong Results for the Third Quarter of 2020 NATICK, Mass.-(BUSINESS WIRE)-October 28, 2020-Cognex Corporation (NASDAQ: CGNX) today reported financial results for the third quarter of 2020. Table 1 below shows selected financial data for Q3-20 compared with Q3-19 and Q2-20, and for the nine months ended September 27, 2020 compared with the same period in 2019. Table 1 (
July 29, 2020	8-K/A	Material Impairments, Costs Associated with Exit or Disposal Activities UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K/A (Amendment No.
July 29, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 29, 2020 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
July 29, 2020	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended June 28, 2020 or ☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 001-34218 COGNEX CORP
July 29, 2020	EX-99.1	Cognex Reports Less-Than-Fabulous Results for the Second Quarter of 2020 Exhibit 99.1 Cognex Reports Less-Than-Fabulous Results for the Second Quarter of 2020 NATICK, Mass.-(BUSINESS WIRE)-July 29, 2020-Cognex Corporation (NASDAQ:CGNX) today reported financial results for the second quarter of 2020. Table 1 below shows selected financial data for Q2-20 compared with Q2-19 and Q1-20, and for the six months ended June 28, 2020 compared with the same period in 2019. Notab
May 28, 2020	EX-99.1	Cognex Announces Significant Cost-Cutting Measures Exhibit 99.1 Cognex Announces Significant Cost-Cutting Measures NATICK, Mass.-(BUSINESS WIRE)-May 28, 2020-Cognex Corporation (NASDAQ: CGNX), the leader in machine vision, today announced that it has taken significant steps to reduce expenses due to the deteriorating market conditions and to position the company for growth when conditions improve. The actions being taken by Cognex include a reduct
May 28, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Material Impairments, Costs Associated with Exit or Disposal Activities UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 26, 2020 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
May 22, 2020	SD	- SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report COGNEX CORPORATION (Exact name of registrant as specified in its charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) One Vision Drive, Natick, Massachusetts 01760-2059 (Address
May 22, 2020	EX-1.01	COGNEX CORPORATION EXHIBIT 1.01 COGNEX CORPORATION CONFLICT MINERALS REPORT FOR THE YEAR ENDED DECEMBER 31, 2019 Cognex Corporation (the Company) is a leading worldwide provider of machine vision products that capture and analyze visual information in order to automate tasks, primarily in manufacturing processes, where vision is required. The Company specializes in machine vision systems that are used to automate th
April 27, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 27, 2020 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
April 27, 2020	EX-99.1	Cognex Reports Results for the First Quarter of 2020 Exhibit 99.1 Cognex Reports Results for the First Quarter of 2020 NATICK, Mass.-(BUSINESS WIRE)-April 27, 2020-Cognex Corporation (NASDAQ: CGNX) today reported financial results for the first quarter of 2020. Table 1 below shows selected financial data for Q1-20 compared with Q1-19 and Q4-19. Table 1 (Dollars in thousands, except per share amounts) Revenue Net Income Net Income per Diluted Share N
April 27, 2020	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 29, 2020 or ☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 001-34218 COGNEX COR
April 24, 2020	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 23, 2020 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
March 13, 2020	DEFA14A	CGNX / Cognex Corp. DEFA14A - - DEFA14A DEFA14A SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
March 13, 2020	DEF 14A	CGNX / Cognex Corp. DEF 14A - - DEF 14A DEF 14A Table of Contents SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
March 12, 2020	EX-99.1	Cognex Authorizes New Stock Buyback Program Exhibit 99.1 Cognex Authorizes New Stock Buyback Program NATICK, Mass.-(BUSINESS WIRE)-March 12, 2020-Cognex Corporation (NASDAQ: CGNX) today announced that the company’s Board of Directors has authorized the purchase of up to $200 million of Cognex common stock in open market transactions or otherwise, subject to market conditions and other relevant factors. This new authorization will commence a
March 12, 2020	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 12, 2020 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
February 14, 2020	SC 13G/A	CGNX / Cognex Corp. / BROWN CAPITAL MANAGEMENT LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 2)* Cognex Corporation (Name of Issuer) Common Stock, $.002 par value (Title of Class of Securities) 192422103 (CUSIP Number) Eddie C. Brown Brown Capital Man
February 13, 2020	EX-4.B	Description of Capital Stock (incorporated by reference to Exhibit 4B of Cognex's Annual Report on Form 10-K for the year ended December 31, 2019 [File No. 1-34218]) cgnxexhibit4bdescription Exhibit 4B Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as amended The common stock, par value $0.
February 13, 2020	EX-99.1	Cognex Reports Fourth Quarter and Full Year 2019 Financial Results Exhibit 99.1 Cognex Reports Fourth Quarter and Full Year 2019 Financial Results NATICK, Mass.-(BUSINESS WIRE)-February 13, 2020-Cognex Corporation (NASDAQ: CGNX) today reported financial results for 2019. Table 1 below shows selected financial data for Q4-19 compared with Q4-18 and Q3-19, and the year ended December 31, 2019 compared with the year ended December 31, 2018. Notably, Cognex recorded
February 13, 2020	EX-18.1	Preferability Letter of Grant Thornton LLP (filed herewith) cognexpreferabilitylette EXHIBIT 18.1 February 13, 2020 Board of Directors Cognex Corporation One Vision Drive Natick, MA 01760 Dear Directors: We are providing this letter solely for inclusion as an exhibit to Cognex Corporation (the “Company”) Form 10-K filing pursuant to Item 601 of Regulation S-K. We have audited the consolidated financial statements included in the Company’s Annual Report on
February 13, 2020	10-K	Annual Report - 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2019 or ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File Number 001-3
February 13, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 13, 2020 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
February 13, 2020	EX-10.U	Form of Restricted Stock Unit Agreement under the 2007 Stock Option and Incentive Plan (incorporated by reference to Exhibit 10U of Cognex's Annual Report on Form 10-K for the year ended December 31, 2019 [File No. 1-34218]) cgnxformofrsuagreement EXHIBIT 10U RESTRICTED STOCK UNIT AWARD AGREEMENT FOR COMPANY EMPLOYEES UNDER THE COGNEX CORPORATION 2007 STOCK OPTION AND INCENTIVE PLAN Name of Grantee: No.
February 13, 2020	EX-99.2	Cognex Names Paul Todgham as Chief Financial Officer Exhibit 99.2 Cognex Names Paul Todgham as Chief Financial Officer NATICK, Mass.-(BUSINESS WIRE)-February 13, 2020-Cognex Corporation (NASDAQ: CGNX), a leader in industrial machine vision, today announced the appointment of Paul Todgham as Senior Vice President of Finance and Chief Financial Officer, effective March 9, 2020. In this role, Mr. Todgham will lead Cognex’s global finance and administra
February 13, 2020	EX-21	Subsidiaries of the registrant (filed herewith) EXHIBIT 21 COGNEX CORPORATION SUBSIDIARIES OF THE REGISTRANT As of December 31, 2019, the registrant had the following direct and indirect subsidiaries, the financial statements of which are all included in the consolidated financial statements of the registrant: NAME OF SUBSIDIARY STATE/COUNTRY OF INCORPORATION PERCENT OWNERSHIP Cognex Asia, Inc.
February 12, 2020	SC 13G/A	CGNX / Cognex Corp. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8)* Name of issuer: Cognex Corp Title of Class of Securities: Common Stock CUSIP Number: 192422103 Date of Event Which Requires Filing of this Statement: December 31, 2019 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13
October 28, 2019	8-K	Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 28, 2019 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
October 28, 2019	EX-99.1	Cognex Reports Third Quarter 2019 Financial Results Exhibit 99.1 Cognex Reports Third Quarter 2019 Financial Results NATICK, Mass.-(BUSINESS WIRE)-October 28, 2019-Cognex Corporation (NASDAQ: CGNX) today reported financial results for the third quarter of 2019. Table 1 below shows selected financial data for Q3-19 compared with Q3-18 and Q2-19, and for the nine months ended September 29, 2019 compared with the same period in 2018. Table 1 (Dollars
October 28, 2019	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 29, 2019 or ☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 001-34218 COGNEX
October 16, 2019	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 16, 2019 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
October 16, 2019	EX-99.1	Cognex Acquires SUALAB to Advance its Leadership in Deep Learning-Based Machine Vision EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Cognex Acquires SUALAB to Advance its Leadership in Deep Learning-Based Machine Vision Acquisition extends company’s deep learning capabilities and accelerates opportunities to automate difficult visual inspection tasks in industrial markets October 16, 2019—NATICK, MA—Cognex Corporation (NASDAQ: CGNX), the leader in machine vision for factory automation
July 29, 2019	EX-99.1	Cognex Reports Results for the Second Quarter Of 2019 Exhibit 99.1 Cognex Reports Results for the Second Quarter Of 2019 NATICK, Mass.-(BUSINESS WIRE)-July 29, 2019-Cognex Corporation (NASDAQ: CGNX) today announced financial results for the second quarter of 2019. Table 1 below shows selected financial data for Q2-19 compared with Q2-18 and Q1-19, and for the six months ended June 30, 2019 compared with the same period in 2018. Table 1 (Dollars in th
July 29, 2019	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 29, 2019 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
July 29, 2019	EX-10.1	Letter Agreement dated April 1, 2019 between Cognex Corporation and John J. Curran* curranagreementv2 Exhibit 10.1 PERSONAL AND CONFIDENTIAL John J. Curran [Address] Re: Resignation Agreement Dear John: This letter confirms your upcoming separation from employment with Cognex Corporation (the “Company”). This letter also proposes an agreement between you and the Company. Entitlements and Obligations Your employment with the Company will end effective May 3, 2019 following the fil
July 29, 2019	EX-10.2	Stock Option Agreement dated May 1, 2019 between Cognex Corporation and Laura MacDonald* lauramacdonald2007plangr Exhibit 10.2 Grant # OT002556 LAURA MACDONALD COGNEX CORPORATION STOCK OPTION AGREEMENT (NON-QUALIFIED) UNDER 2007 STOCK OPTION AND INCENTIVE PLAN As Amended and Restated AGREEMENT entered into as of 05/01/2019, by and between COGNEX CORPORATION, a Massachusetts corporation (the "Company") and the undersigned employee of the Company or one of its subsidiaries (the "Optione
July 29, 2019	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended June 30, 2019 or ☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 001-34218 COGNEX CORP
May 24, 2019	SD	CGNX / Cognex Corp. SD - - SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report COGNEX CORPORATION (Exact name of registrant as specified in its charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) One Vision Drive, Natick, Massachusetts 01760-2059 (Address
May 24, 2019	EX-1.01	COGNEX CORPORATION EXHIBIT 1.01 COGNEX CORPORATION CONFLICT MINERALS REPORT FOR THE YEAR ENDED DECEMBER 31, 2018 Cognex Corporation (the Company) is a leading worldwide provider of machine vision products that capture and analyze visual information in order to automate tasks, primarily in manufacturing processes, where vision is required. The Company specializes in machine vision systems that are used to automate th
April 29, 2019	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 25, 2019 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
April 29, 2019	EX-99.1	Cognex Reports Results for the First Quarter of 2019 Exhibit 99.1 Cognex Reports Results for the First Quarter of 2019 NATICK, Mass.-(BUSINESS WIRE)-April 29, 2019-Cognex Corporation (NASDAQ: CGNX) today announced financial results for the first quarter of 2019. Table 1 below shows selected financial data for Q1-19 compared with Q1-18 and Q4-18. Table 1 (Dollars in thousands, except per share amounts) Revenue Net Income Net Income per Diluted Share
April 29, 2019	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [ X ] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2019 or [ ] Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 001-34218 COGN
April 29, 2019	EX-3.4	Articles of Amendment to Restated Articles of Organization of Cognex Corporation, effective April 26, 2019 (incorporated by reference to Exhibit 3.4 of Cognex's Quarterly Report on Form 10-Q for the quarter ended March 31, 2019 [File No. 1-34218]) cgnxarticlesofamendment Cognex Corporation 84 State Street, Boston, Massachusetts 02109 Articles 3 and 4 February 1, 2019 Articles 3 and 4 are amended by deleting in its entirety the section titled "Resolutions of Directors Establishing Series E Junior Participating Cumulative Preferred Stock" from such Articles.
April 26, 2019	8-K	Submission of Matters to a Vote of Security Holders Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 25, 2019 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
April 4, 2019	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 1, 2019 Cognex Corporation (Exact Name of Registrant as Specified in Charter) Massachusetts (State or Other Jurisdiction of Incorporation) 001-34218 04-2713778 (Commission File Number) (IRS Employer Identification No.
March 13, 2019	DEFA14A	CGNX / Cognex Corp. DEFA14A DEFA14A SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
March 13, 2019	DEF 14A	CGNX / Cognex Corp. DEF 14A DEF 14A Table of Contents SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
February 14, 2019	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 14, 2019 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
February 14, 2019	EX-99.1	Cognex Reports Record Fourth Quarter and Full Year Results for 2018 Exhibit 99.1 Cognex Reports Record Fourth Quarter and Full Year Results for 2018 NATICK, Mass.-(BUSINESS WIRE)-February 14, 2019-Cognex Corporation (NASDAQ: CGNX) today announced financial results for 2018. Table 1 below shows selected financial data for Q4-18 compared with Q4-17 and Q3-18, and the year ended December 31, 2018 compared with the year ended December 31, 2017. Earnings per share for
February 14, 2019	EX-21	Subsidiaries of the registrant (filed herewith) EXHIBIT 21 COGNEX CORPORATION SUBSIDIARIES OF THE REGISTRANT As of December 31, 2018, the registrant had the following direct and indirect subsidiaries, the financial statements of which are all included in the consolidated financial statements of the registrant: NAME OF SUBSIDIARY STATE/COUNTRY OF INCORPORATION PERCENT OWNERSHIP Cognex Asia, Inc.
February 14, 2019	10-K	CGNX / Cognex Corp. 10-K (Annual Report) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) [ X ] Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2018 or [ ] Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File Number
February 14, 2019	SC 13G/A	CGNX / Cognex Corp. / BROWN CAPITAL MANAGEMENT LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 1)* Cognex Corporation (Name of Issuer) Common Stock, $.002 par value (Title of Class of Securities) 192422103 (CUSIP Number) Eddie C. Brown Brown Capital Man
February 11, 2019	SC 13G/A	CGNX / Cognex Corp. / VANGUARD GROUP INC Passive Investment cognexcorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 7 )* Name of issuer: Cognex Corp Title of Class of Securities: Common Stock CUSIP Number: 192422103 Date of Event Which Requires Filing of this Statement: December 31, 2018 Check the appropriate box to designate
October 29, 2018	EX-99.1	Cognex Reports Results for the Third Quarter of 2018 Exhibit 99.1 Cognex Reports Results for the Third Quarter of 2018 NATICK, Mass.-(BUSINESS WIRE)-October 29, 2018-Cognex Corporation (NASDAQ: CGNX) today announced financial results for the third quarter of 2018. Table 1 below shows selected financial data for Q3-18 compared with Q3-17 and Q2-18, and the first nine months of 2018 compared with the first nine months of 2017. All periods presented re
October 29, 2018	8-K	Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 29, 2018 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
October 29, 2018	10-Q	CGNX / Cognex Corp. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [ X ] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2018 or [ ] Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 001-34218
July 30, 2018	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 30, 2018 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
July 30, 2018	EX-99.1	Cognex Reports Results for the Second Quarter of 2018 Exhibit 99.1 Cognex Reports Results for the Second Quarter of 2018 NATICK, Mass.-(BUSINESS WIRE)-July 30, 2018-Cognex Corporation (NASDAQ: CGNX) today announced financial results for the second quarter of 2018. Table 1 below shows selected financial data for Q2-18 compared with Q2-17 and Q1-18, and the first six months of 2018 compared with the first six months of 2017. All periods presented refle
July 30, 2018	10-Q	CGNX / Cognex Corp. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [ X ] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended July 1, 2018 or [ ] Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 001-34218 COGNEX
June 8, 2018	SC 13G	CGNX / Cognex Corp. / BROWN CAPITAL MANAGEMENT LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 0)* Cognex Corporation (Name of Issuer) Common Stock, $.002 par value (Title of Class of Securities) 192422103 (CUSIP Number) Eddie C. Brown Brown Capital Man
May 25, 2018	SD	CGNX / Cognex Corp. SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report COGNEX CORPORATION (Exact name of registrant as specified in its charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) One Vision Drive, Natick, Massachusetts 01760-2059 (Address
May 25, 2018	EX-1.01	COGNEX CORPORATION EXHIBIT 1.01 COGNEX CORPORATION CONFLICT MINERALS REPORT FOR THE YEAR ENDED DECEMBER 31, 2017 Cognex Corporation (the Company) is a leading worldwide provider of machine vision products that capture and analyze visual information in order to automate tasks, primarily in manufacturing processes, where vision is required. The Company specializes in machine vision systems that are used to automate th
May 7, 2018	EX-99.1	Cognex Corporation 2001 General Stock Option Plan, as Amended and Restated. EX-99.1 Exhibit 99.1 COGNEX CORPORATION 2001 GENERAL STOCK OPTION PLAN As Amended and Restated 1. PURPOSE OF THE PLAN. This stock option plan (as amended and restated, the “Plan”) is intended to provide a means by which eligible employees of Cognex Corporation (the “Company”) and any present or future subsidiaries of the Company may purchase common stock in the Company through the exercise of stoc
May 7, 2018	EX-4.2	Articles of Amendment to Restated Articles of Organization, effective May 2, 2018 (incorporated herein by reference to Exhibit 4.2 of the Company’s Registration Statement on Form S-8 filed with the SEC on May 7, 2018, Reg. No. 333-224716). EX-4.2 Exhibit 4.2 The Commonwealth of Massachusetts William Francis Galvin Secretary of the Commonwealth One Ashburton Place, Boston, Massachusetts 02108-1512 FORM MUST BE TYPED Articles of Amendment FORM MUST BE TYPED (General Laws Chapter 156D, Section 10.06; 950 CMR 113.34) (1) Exact name of corporation: Cognex Corporation (2) Registered office address: One Vision Drive, Natick, Massachusetts
May 7, 2018	S-8 POS	CGNX / Cognex Corp. S-8 POS S-8 POS As filed with the Securities and Exchange Commission on May 7, 2018 Registration No.
May 7, 2018	S-8	CGNX / Cognex Corp. S-8 S-8 As filed with the Securities and Exchange Commission on May 7, 2018 Registration No.
May 7, 2018	EX-4.2	Articles of Amendment to Restated Articles of Organization of Cognex Corporation, effective May 2, 2018 (incorporated by reference to Exhibit 4.2 of Cognex's Registration Statement on Form S-8 [Registration No. 333-224716]) EX-4.2 Exhibit 4.2 The Commonwealth of Massachusetts William Francis Galvin Secretary of the Commonwealth One Ashburton Place, Boston, Massachusetts 02108-1512 FORM MUST BE TYPED Articles of Amendment FORM MUST BE TYPED (General Laws Chapter 156D, Section 10.06; 950 CMR 113.34) (1) Exact name of corporation: Cognex Corporation (2) Registered office address: One Vision Drive, Natick, Massachusetts
May 7, 2018	EX-99.1	Cognex Corporation 2001 General Stock Option Plan, as amended and restated (incorporated by reference to Exhibit 99.1 to Cognex's Registration Statement on Form S-8 [Registration No. 333-224716]) EX-99.1 Exhibit 99.1 COGNEX CORPORATION 2001 GENERAL STOCK OPTION PLAN As Amended and Restated 1. PURPOSE OF THE PLAN. This stock option plan (as amended and restated, the “Plan”) is intended to provide a means by which eligible employees of Cognex Corporation (the “Company”) and any present or future subsidiaries of the Company may purchase common stock in the Company through the exercise of stoc
April 30, 2018	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 30, 2018 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
April 30, 2018	EX-99.1	Cognex Reports Results for the First Quarter of 2018 Exhibit 99.1 Cognex Reports Results for the First Quarter of 2018 NATICK, Mass.-(BUSINESS WIRE)-April 30, 2018-Cognex Corporation (NASDAQ: CGNX) today announced financial results for the first quarter of 2018. Table 1 below shows selected financial data for Q1-18 compared with Q1-17 and Q4-17. All periods presented reflect the two-for-one stock split in Q4-17. Table 1* (Dollars in thousands, excep
April 30, 2018	EX-10.1	Letter Agreement dated February 15, 2018 between Cognex Corporation and J. Bruce Robinson (incorporated by reference to Cognex's Quarterly Report on Form 10-Q for the quarter ended April 30, 2018 [File No. 1-34218]) EXHIBIT 10.1 February 15, 2018 delivered by email J. Bruce Robinson Dear Bruce: We have received your letter of resignation from our Board of Directors dated February 15, 2018. On behalf of the Board, I would like to thank you for your past service to our company. This letter is to confirm that, as a result of your agreement to provide consulting services as an Assistant Secretary of Cognex throug
April 30, 2018	10-Q	CGNX / Cognex Corp. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [ X ] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended April 1, 2018 or [ ] Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 001-34218 COGNE
April 27, 2018	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 25, 2018 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
March 16, 2018	DEFA14A	CGNX / Cognex Corp. DEFA14A DEFA14A SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
March 14, 2018	DEF 14A	CGNX / Cognex Corp. DEF 14A DEF 14A Table of Contents SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
February 27, 2018	PRE 14A	CGNX / Cognex Corp. PRE 14A PRE 14A Table of Contents SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
February 21, 2018	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 15, 2018 Cognex Corporation (Exact Name of Registrant as Specified in Charter) Massachusetts (State or Other Jurisdiction of Incorporation) 001-34218 04-2713778 (Commission File Number) (IRS Employer Identification No.
February 15, 2018	EX-99.1	Cognex Reports Record Revenue, Earnings and EPS for 2017 Exhibit 99.1 Cognex Reports Record Revenue, Earnings and EPS for 2017 NATICK, Mass.-(BUSINESS WIRE)-February 15, 2018-Cognex Corporation (NASDAQ: CGNX) today announced financial results for the fourth-quarter and full-year of 2017. Table 1 below shows selected financial data for Q4-17 compared with Q4-16 and Q3-17, and the year ended December 31, 2017 compared with the year ended December 31, 2016
February 15, 2018	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 15, 2018 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
February 15, 2018	EX-10.G	Cognex Corporation 2001 General Stock Option Plan, as amended and restated (filed herewith) EXHIBIT 10G COGNEX CORPORATION 2001 GENERAL STOCK OPTION PLAN As Amended and Restated 1.
February 15, 2018	EX-10.Q	Summary of Cognex Annual Bonus Program (incorporated by reference to Exhibit 10Q of Cognex's Annual Report on Form 10-K for the year ended December 31, 2017 [File No. 1-34218]) EXHIBIT 10Q Summary of Cognex Corporation Annual Bonus Program Cognex Corporation (the “Company”) maintains a performance-based annual bonus program (the “Bonus Program”) for employees (including the Company’s executive officers), other than those employees on a sales commission plan.
February 15, 2018	EX-10.H	Cognex Corporation 2007 Stock Option and Incentive Plan, as amended and restated (incorporated by reference to Exhibit 10H of Cognex's Annual Report on Form 10-K for the year ended December 31, 2017 [File No. 1-34218]) EXHIBIT 10H COGNEX CORPORATION 2007 STOCK OPTION AND INCENTIVE PLAN AS AMENDED AND RESTATED SECTION 1.
February 15, 2018	EX-21	Subsidiaries of the registrant (filed herewith) EXHIBIT 21 COGNEX CORPORATION SUBSIDIARIES OF THE REGISTRANT As of December 31, 2017, the registrant had the following direct and indirect subsidiaries, the financial statements of which are all included in the consolidated financial statements of the registrant: NAME OF SUBSIDIARY STATE/COUNTRY OF INCORPORATION PERCENT OWNERSHIP Cognex Asia, Inc.
February 15, 2018	EX-10.O	Form of Stock Option Agreement under 2001 General Stock Option Plan (incorporated by reference to Exhibit 10O of Cognex's Annual Report on Form 10-K for the year ended December 31, 2017 [File No. 1-34218]) EXHIBIT 10O Grant # [Name] COGNEX CORPORATION STOCK OPTION AGREEMENT (NON-QUALIFIED) UNDER 2001 GENERAL STOCK OPTION PLAN As Amended and Restated AGREEMENT entered into as of , by and between COGNEX CORPORATION, a Massachusetts corporation (the "Company") and the undersigned employee of the Company or one of its subsidiaries (the "Optionee").
February 15, 2018	10-K	CGNX / Cognex Corp. 10-K (Annual Report) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) [ X ] Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2017 or [ ] Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File Number
February 14, 2018	SC 13G/A	CGNX / Cognex Corp. / BROWN CAPITAL MANAGEMENT LLC Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 7)* Cognex Corporation (Name of Issuer) Common Stock, Par Value $0.002 (Title of Class of Securities) 192422103 (CUSIP Number) December 31, 2017 (Date of Eve
February 9, 2018	SC 13G/A	CGNX / Cognex Corp. / VANGUARD GROUP INC Passive Investment cognexcorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 6 )* Name of issuer: Cognex Corp Title of Class of Securities: Common Stock CUSIP Number: 192422103 Date of Event Which Requires Filing of this Statement: December 31, 2017 Check the appropriate box to designate
October 30, 2017	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 30, 2017 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
October 30, 2017	EX-99.1	Cognex Reports Record Results for the Third Quarter of 2017 Machine Vision Company Reports Record Quarterly Revenue, Net Income and Earnings per Share from Continuing Operations Exhibit 99.1 Cognex Reports Record Results for the Third Quarter of 2017 Machine Vision Company Reports Record Quarterly Revenue, Net Income and Earnings per Share from Continuing Operations NATICK, Mass.-(BUSINESS WIRE)-October 30, 2017-Cognex Corporation (NASDAQ: CGNX) today announced its financial results for the third quarter of 2017 (ended October 1, 2017). Table 1 below shows selected financ
October 30, 2017	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [ X ] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended October 1, 2017 or [ ] Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 001-34218 COG
July 31, 2017	EX-99.1	Cognex Reports Record Results for the Second Quarter of 2017 Machine Vision Company Reports Record Quarterly Revenue, Net Income and Earnings per Share from Continuing Operations Exhibit 99.1 Cognex Reports Record Results for the Second Quarter of 2017 Machine Vision Company Reports Record Quarterly Revenue, Net Income and Earnings per Share from Continuing Operations NATICK, Mass.-(BUSINESS WIRE)-July 31, 2017-Cognex Corporation (NASDAQ: CGNX) today announced its financial results for the second quarter of 2017 (ended July 2, 2017). Table 1 below shows selected financial
July 31, 2017	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 31, 2017 Cognex Corportation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
July 31, 2017	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [ X ] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended July 2, 2017 or [ ] Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 001-34218 COGNEX
May 30, 2017	EX-1.01	COGNEX CORPORATION Exhibit EXHIBIT 1.01 COGNEX CORPORATION CONFLICT MINERALS REPORT FOR THE YEAR ENDED DECEMBER 31, 2016 Cognex Corporation (the Company) is a leading worldwide provider of machine vision products that capture and analyze visual information in order to automate tasks, primarily in manufacturing processes, where vision is required. The Company specializes in machine vision systems that are used to aut
May 30, 2017	SD	Cognex SD Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report COGNEX CORPORATION (Exact name of registrant as specified in its charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) One Vision Drive, Natick, Massachusetts 01760-2059
May 2, 2017	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8?K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 27, 2017 Cognex Corporation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.
May 1, 2017	10-Q	Cognex 10-Q (Quarterly Report) Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [ X ] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended April 2, 2017 or [ ] Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 001-34
May 1, 2017	EX-99.1	Cognex Reports Record First Quarter Results for Revenue, Net Income and Earnings Per Share Exhibit 99.1 Cognex Reports Record First Quarter Results for Revenue, Net Income and Earnings Per Share NATICK, Mass.-(BUSINESS WIRE)-May 1, 2017-Cognex Corporation (NASDAQ: CGNX) today announced that the company set new first quarter records for revenue, net income and earnings per share in the first quarter of 2017. In Table 1 below, selected financial data for the quarter ended April 2, 2017 is
May 1, 2017	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 1, 2017 Cognex Corportation (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File N
March 15, 2017	DEFA14A	Cognex DEFA14A DEFA14A SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
March 15, 2017	DEF 14A	Cognex DEF 14A DEF 14A Table of Contents SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
February 16, 2017	10-K	Cognex 10-K (Annual Report) Document Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
February 16, 2017	8-K	Cognex COGNEX CORPORATION 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 15, 2017 COGNEX CORPORATION (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission F
February 16, 2017	EX-99.1	Cognex Reports Record Results for Fourth Quarter and Full Year Exhibit 99.1 Cognex Reports Record Results for Fourth Quarter and Full Year NATICK, Mass.-(BUSINESS WIRE)-February 16, 2017-Cognex Corporation (NASDAQ: CGNX) today announced that the company set new records for both fourth quarter and annual revenue, net income and earnings per share in 2016. In Table 1 below, selected financial data for the quarter and year ended December 31, 2016 is compared to
February 16, 2017	EX-21	COGNEX CORPORATION SUBSIDIARIES OF THE REGISTRANT EXHIBIT 21 COGNEX CORPORATION SUBSIDIARIES OF THE REGISTRANT As of December 31, 2016, the registrant had the following subsidiaries, the financial statements of which are all included in the consolidated financial statements of the registrant: NAME OF SUBSIDIARY STATE/COUNTRY OF INCORPORATION PERCENT OWNERSHIP Cognex Asia, Inc.
February 10, 2017	SC 13G/A	CGNX / Cognex Corp. / VANGUARD GROUP INC Passive Investment cognexcorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 5 )* Name of issuer: Cognex Corp Title of Class of Securities: Common Stock CUSIP Number: 192422103 Date of Event Which Requires Filing of this Statement: December 31, 2016 Check the appropriate box to designate
February 9, 2017	SC 13G/A	CGNX / Cognex Corp. / BROWN CAPITAL MANAGEMENT LLC Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 6)* Cognex Corporation (Name of Issuer) Common Stock, Par Value $0.002 (Title of Class of Securities) 192422103 (CUSIP Number) December 31, 2016 (Date of Eve
October 31, 2016	10-Q	Cognex 10-Q (Quarterly Report) Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [ X ] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended October 2, 2016 or [ ] Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 001-
October 31, 2016	EX-99.1	Cognex Reports Record Net Income and Earnings Per Share from Continuing Operations Exhibit 99.1 Cognex Reports Record Net Income and Earnings Per Share from Continuing Operations NATICK, Mass.-(BUSINESS WIRE)-October 31, 2016-Cognex Corporation (NASDAQ: CGNX) today announced its financial results for the third quarter of 2016. In Table 1 below, selected financial data for the quarter and nine months ended October 2, 2016 is compared to the second quarter of 2016, the third quart
October 31, 2016	8-K	Cognex COGNEX CORPORATION 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 31, 2016 COGNEX CORPORATION (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission Fi
August 1, 2016	EX-99.1	Cognex Reports Record Second Quarter Revenue and Earnings Per Share from Continuing Operations Exhibit 99.1 Cognex Reports Record Second Quarter Revenue and Earnings Per Share from Continuing Operations NATICK, Mass.-(BUSINESS WIRE)-August 1, 2016-Cognex Corporation (NASDAQ: CGNX) today announced its financial results for the second quarter of 2016. In Table 1 below, selected financial data for the quarter ended July 3, 2016 is compared to the first quarter of 2016, the second quarter of 20
August 1, 2016	8-K	Cognex COGNEX CORPORATION 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 1, 2016 COGNEX CORPORATION (Exact name of registrant as specified in charter) Massachusetts 001-34218 04-2713778 (State or other jurisdiction of incorporation) (Commission File
August 1, 2016	10-Q	Cognex 10-Q (Quarterly Report) Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [ X ] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended July 3, 2016 or [ ] Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 001-342
August 1, 2016	EX-3.1	Restated Articles of Organization of Cognex Corporation effective June 27, 1989, as amended through May 5, 2016 (incorporated by reference to Exhibit 3.1 of Cognex's Quarterly Report on Form 10-Q for the quarter ended July 3, 2016 [File No. 1-34218]) Exhibit Exhibit 3.1 Restated Articles of Organization of Cognex Corporation The Commonwealth of Massachusetts FEDERAL IDENTIFICATION Examiner MICHAEL JOSEPH CONNOLLY Secretary of State ONE ASHBURTON PLACE, BOSTON, MASS: 02108 No. 04-2713778 RESTATED ARTICLES OF ORGANIZATION GENERAL LAWS, CHAPTER 156B, SECTION 74 This certificate must be submitted to the Secretary of the Commonwealth within sixty d

MX:CGNX
DE:CGZ	37,85 €
GB:0I14	44,36 $
IT:1CGNX	38,72 €

CGNX / Cognex Corporation - Документы SEC, Годовой отчет, Доверенное заявление

Основная статистика

SEC Filings

SEC Filings (Chronological Order)

Other Listings